the current research on momelotinib for myelofibrosis
Published 8 years ago • 380 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
4:25
update on momelotinib for myelofibrosis
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
4:15
the latest data on momelotinib for mpns
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
29:22
jcs 29. single-cell multiome and ai reveal eye disease variants
-
34:35
current management of myelofibrosis - ronald hoffman, md
-
4:17
treatment sequencing and ongoing clinical trials in anemic myelofibrosis
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
1:53
parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib
-
2:26
assessing the impact of momelotinib on transfusion burden in mf: analysis of simplify-1 & momentum
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
2:20
momentum & the potential impact of approval of momelotinib in myelofibrosis
-
2:20
quantifying the anemia benefit of momelotinib in mf: analysis of data from simplify-1 & simplify-2
-
1:34
pelabresib in myelofibrosis: the manifest trials
-
1:28
momelotinib in 2024: how should this agent be used in mf with anemia?
-
1:44
momelotinib: a promising agent in mf
-
4:48
an insight into the management of cytopenias in mf
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy